- Citing sources close to the deal, CNBC reports that a Hong Kong biotech Prenetics is set to merge with Artisan Acquisition Corp ARTA, a special purpose acquisition company (SPAC), in a deal that will value the new entity at more than $1.3 billion.
- In the deal, Prenetics will get the $339 million raised in the SPAC and another $60 million in PIPE financing with investment firm Aspex and PAG.
- The merger is expected to be completed by the end of 2021, CNBC reported.
- Prenetics is a diagnostic and genetic testing company with significant operations in Hong Kong and the U.K.
- It was founded by serial entrepreneur Danny Yeung and will become the first billion-dollar start-up in Hong Kong to go public.
- The Company expects to clock over 200 million in 2021. Annual revenue is expected to reach $600 million by 2025, said the source.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
